References
- Schwartz R H, Wientzen R L, Jr, Pedreira F, Feroli E J, Mella G W, Guandolo V L. Penicillin V for group A streptococcal pharyngotonsillitis. A randomized trial of seven vs ten days' therapy. JAMA 1981; 246: 1790–1795
- Roos K, Holm S E, Ekedahl C. Treatment failure in acute streptococcal tonsillitis in children over the age of 10 and in adults. Scand J Infect Dis 1985; 17: 357–365
- Kim K S, Kaplan E L. Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis. J Pediatr 1985; 107: 681–684
- Brook I. Role of beta-lactamase producing bacteria in the failure of penicillin to eradicate group A streptococci. Pediatr Infect Dis 1985; 4: 491–495
- Roos K, Grahn E, Holm S E. Evaluation of beta-lactamase activity and microbial interference in treatment failures of acute streptococcal tonsillitis. Scand J Infect Dis 1986; 18: 313–319
- Pichichero M E, Disney F A, Aronovitz G H, Talpey W B, Green J L, Francis A B. Randomized, single-blind evaluation of cefadroxil and phenoxymethyl penicillin in the treatment of streptococcal pharyngitis. Antimicrob Agents Chemother 1987; 31: 903–906
- Milatovic D, Knauer J. Cefadroxil versus penicillin in the treatment of streptococcal tonsillopharyngitis. Eur J Clin Microbiol Infect Dis 1989; 8: 282–288
- Holm S E, Roos K, Strömberg A. A randomized study of treatment of streptococcal pharyngotonsillitis with cefadroxil or phenoxymethylpenicillin (penicillin V). Pediatr Infect Dis J 1991; 10: S68–S71
- Cao C, Chin N X, Neu H C. In-vitro activity and beta-lactamase stability of LY163892. J Antimicrob Chemother 1988; 22: 155–165
- Jorgensen J H, Redding J S, Maher L A. Influence of storage and susceptibility test conditions on stability and activity of LY163892 and four other cephalosporins. Antimicrob Agents Chemother 1988; 32: 1477–1480
- Howard A J, Dunkin K T. Comparative in-vitro activity of a new oral carbacephem, LY163892. J Antimicrob Chemother 1988; 22: 445–456
- Ishida K, Guze P A, Kalmanson G M, Albrandt K, Guze L B. Variables in demonstrating methicillin tolerance in Staphylococcus aureus strains. Antimicrob Agents Chemother 1982; 21: 688–690
- Taylor P C, Schoenknecht F D, Sherris J C, Linner E C. Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus influence and significance of technical factors. Antimicrob Agents Chemother 1983; 23: 142–150
- Woolfrey B F, Lally R T, Ederer M N. Evaluation of oxacillin tolerance in Staphylococcus aureus a novel method. Antimicrob Agents Chemother 1985; 28: 381–388
- Numan M, Banck G, Thore M. Penicillin tolerance in Arcanobacterium haemolyticum. J Infect Dis 1990; 161: 261–265
- Thrupp L D. Susceptibility testing of antibiotics in liquid media. Antibiotics in laboratory medicine, V Lorian, Baltimore 1980
- Handwerger S, Tomasz A. Antibiotic tolerance among clinical isolates of bacteria. Rev Infect Dis 1985; 7: 368–386
- Grahn E, Holm S E, Roos K. Penicillin tolerance in beta-streptococci isolated from patients with streptococcal tonsillitis. Scand J Infect Dis 1987; 19: 421–426
- Smith T D, Huskins W C, Kim S K, Kaplan E L. Efficacy of beta-lactamase-resistant penicillin and influence of penicillin tolerance in eradicating streptococci from the pharynx after failure of penicillin therapy for group A streptococcal pharyngitis. J Pediatr 1987; 110: 777–782